E 5.4565473
li 4.717585
ĠLilly 2.1377902
Ġ& 2.160921
ĠCo 0.27580357
's 4.905011
ĠThird 10.962066
- 1.1860043
Qu 0.37589028
arter 0.0006795559
ĠProf 4.1992655
its 0.008062494
ĠEx 5.858339
pected 0.79714257
Ġto 0.57777107
ĠRise 1.811112
, 3.7875798
Ġbut 2.2654016
ĠConcern 6.877354
s 0.21972005
ĠOver 2.4823258
ĠProfit 6.7768145
ĠMarg 1.6129059
ins 0.20570768
ĠRemain 2.044665
ĠEli 5.184241
ĠLilly 0.010949035
Ġ& 0.29842067
ĠCo 0.021167558
Ġis 2.0511906
Ġexpected 0.45236257
Ġto 0.014396355
Ġreport 0.6098914
Ġhigher 2.7224202
Ġthird 0.43485004
- 0.014156747
quarter 0.0021488057
Ġprofits 1.2740921
Ġand 4.109496
Ġrevenue 2.4258108
Ġwhen 2.0861237
Ġthe 1.6180098
Ġcompany 0.7831519
Ġannounces 2.3342638
Ġearnings 2.0206718
Ġon 0.93100065
ĠTuesday 1.3759732
, 0.74955434
Ġaccording 2.7160141
Ġto 0.01070278
Ġanalysts 0.62759113
bytes:\xe2\x80 6.9841604
bytes:\x99 0.01694025
Ġestimates 0.38243636
Ġcompiled 1.4803314
Ġby 0.009615807
ĠBloomberg 0.51520485
. 0.1795935
ĠHowever 2.3903794
, 0.015450393
Ġconcerns 2.3378985
Ġremain 1.3138628
Ġover 0.92609686
Ġnarrowing 7.7641764
Ġprofit 0.13293155
Ġmargins 0.010845936
Ġfor 2.7196107
Ġthe 0.6099004
Ġpharmaceutical 2.6404788
Ġgiant 1.3128812
. 0.4851069
ĠLilly 2.5844781
Ġis 1.4284171
Ġforecast 3.35455
Ġto 0.18503536
Ġpost 1.5412073
Ġa 1.882977
Ġ12 4.4792957
% 1.092384
Ġincrease 0.9936613
Ġin 0.025649535
Ġearnings 2.054689
Ġper 0.9488578
Ġshare 0.008426326
Ġto 0.90007406
Ġ$ 0.17964886
1 0.4287201
. 0.0027450628
55 4.7882943
Ġand 2.6544528
Ġa 0.9449061
Ġ7 2.7400897
. 1.3699573
3 2.1262243
% 0.008793599
Ġrise 0.7487152
Ġin 0.010505072
Ġrevenue 0.28885347
Ġto 0.043132346
Ġ$ 0.016693609
5 0.99829435
. 0.032490894
43 4.842788
Ġbillion 0.03026989
, 1.0551726
Ġcompared 2.6435695
Ġwith 0.6034855
Ġthe 0.5935008
Ġsame 0.6320555
Ġquarter 1.8850029
Ġlast 0.5712295
Ġyear 0.006862271
. 0.44741032
ĠOverall 5.952908
, 0.21604235
ĠLilly 2.7451665
Ġhas 2.0741715
Ġexceeded 4.4554224
Ġanalysts 0.89879155
bytes:\xe2\x80 0.17949128
bytes:\x99 0.0005562772
Ġearnings 1.522206
Ġexpectations 1.4220697
Ġfor 1.3340521
Ġnine 3.317247
Ġconsecutive 0.90752524
Ġquarters 0.010913785
. 0.60975164
ĠThe 1.809028
Ġcompany 0.46094975
bytes:\xe2\x80 1.2830037
bytes:\x99 0.00034428947
s 0.00042961474
Ġshare 3.9075239
Ġprice 0.11506575
Ġis 1.8737932
Ġup 0.8458691
Ġ18 4.460185
% 0.44380313
Ġso 2.017805
Ġfar 0.00065468537
Ġthis 0.22136389
Ġyear 0.0058342037
, 0.6630546
Ġoutper 3.0715046
forming 0.00095163693
Ġthe 0.17304857
ĠS 0.7558664
& 0.0010172646
P 0.0006637518
Ġ500 0.02767305
. 3.191526
ĠThe 2.4837897
Ġexpected 6.107984
Ġearnings 1.372174
Ġgrowth 1.5329548
Ġis 1.1548816
Ġfueled 4.323303
Ġprimarily 3.555699
Ġby 0.013021331
Ġhigher 3.276998
Ġsales 0.9056152
Ġof 0.36061943
Ġnew 3.8382022
Ġproducts 2.232049
, 0.87624633
Ġincluding 0.5998705
Ġthe 1.5998942
Ġdiabetes 2.5215597
Ġdrugs 3.779505
ĠJ 2.3977697
ard 0.0029713733
iance 0.0025421083
Ġand 0.18039544
ĠTr 0.3914661
ul 0.0016582182
icity 0.0033650578
Ġas 3.9234397
Ġwell 0.002751336
Ġas 0.007412282
Ġthe 0.7286983
Ġcancer 1.8647944
Ġtreatment 1.7938142
ĠVer 5.5056777
zen 0.004640997
io 0.014969704
. 0.29669896
ĠTr 6.268129
ul 0.0040244586
icity 0.00462962
Ġhas 2.6738
Ġbeen 1.1552647
ĠLilly 3.4113393
's 1.3396335
Ġfastest 2.114473
- 0.18461415
growing 0.2527616
Ġproduct 1.1656353
Ġand 3.5627677
Ġsales 4.169985
Ġrose 4.2174273
Ġover 5.0653567
Ġ50 1.50739
% 0.027004313
Ġlast 2.8212852
Ġquarter 0.25747445
Ġcompared 3.1921146
Ġto 0.8282977
Ġa 2.0493982
Ġyear 0.018467598
Ġearlier 0.6174544
. 0.23624322
ĠHowever 1.7977648
, 0.0036865075
Ġrevenue 5.1614
Ġfrom 1.0219462
Ġsome 4.5359683
Ġof 0.49364337
ĠLilly 0.45732936
bytes:\xe2\x80 1.2255204
bytes:\x99 0.0014550679
s 0.0005850234
Ġolder 0.90666556
Ġblockbuster 3.0904
Ġdrugs 0.26280755
Ġlike 3.5203242
ĠC 2.9329228
ial 0.0012364413
is 0.0013952572
Ġand 0.6996503
ĠFort 5.48672
e 0.044833034
o 0.002222161
Ġdeclined 2.768594
Ġdue 4.1226945
Ġto 0.016119942
Ġloss 4.565626
Ġof 0.015240975
Ġpatent 0.48945653
Ġexclus 1.3818446
ivity 0.0049400944
Ġand 2.0811176
Ġcompetition 0.817156
Ġfrom 0.34064585
Ġgeneric 1.1576774
Ġalternatives 2.2653458
. 0.0836139
ĠWhile 4.1148744
ĠLilly 1.6364467
bytes:\xe2\x80 1.1565588
bytes:\x99 0.0007075915
s 0.00024453807
Ġtop 3.7022612
- 0.78909755
line 0.40618291
Ġresults 3.446552
Ġhave 1.8400214
Ġbeen 0.62021965
Ġsolid 2.5341253
, 0.307715
Ġprofit 2.6637444
Ġmargins 0.04802658
Ġhave 0.28442267
Ġbeen 0.7993698
Ġunder 2.3192582
Ġpressure 0.057653546
Ġdue 1.4219508
Ġto 0.020176502
Ġhigher 2.289075
Ġcosts 1.9158492
. 3.2445488
ĠThe 1.5611088
Ġcompany 0.20799856
Ġhas 1.5005585
Ġinvested 4.0287185
Ġheavily 0.6864998
Ġin 0.21624765
Ġresearch 1.0180517
Ġand 0.104149684
Ġdevelopment 0.047602333
Ġto 1.4981623
Ġrest 8.168219
ock 0.3909492
Ġits 0.105244234
Ġproduct 2.602858
Ġpipeline 0.07508135
Ġas 3.1043856
Ġwell 1.2488904
Ġas 0.00897076
Ġin 1.443769
Ġmarketing 1.4529581
Ġand 1.404555
Ġpromotions 4.316426
Ġto 0.70620894
Ġdrive 2.9285483
Ġsales 0.50340396
Ġof 0.7441631
Ġnew 1.0634413
Ġdrugs 1.1037872
. 0.15372667
ĠLilly 1.4954097
bytes:\xe2\x80 1.3024436
bytes:\x99 0.0004871615
s 0.0002429912
Ġoperating 1.8590139
Ġmargin 1.4619254
Ġdeclined 2.462697
Ġto 0.5857758
Ġ21 3.403047
% 1.2331483
Ġlast 1.610473
Ġquarter 0.08104607
Ġfrom 0.5278614
Ġ24 1.7050349
% 0.22274774
Ġa 0.5744484
Ġyear 0.0009779445
Ġago 1.5756581
. 0.46044537
ĠLooking 5.5193768
Ġahead 0.22863135
, 0.07645471
ĠLilly 0.6434463
Ġaims 6.7285867
Ġto 0.010696032
Ġlaunch 3.3236077
Ġ20 5.270131
Ġnew 0.7769611
Ġproducts 0.7747744
Ġbetween 2.1017
Ġ2018 1.8434191
Ġand 0.032560475
Ġ20 2.4604046
23 0.05576264
Ġto 2.9196649
Ġdrive 2.5088692
Ġfuture 1.6318326
Ġgrowth 0.39961925
. 0.19203596
Ġ" 4.087402
We 1.0120414
Ġremain 3.4232213
Ġconfident 1.838901
Ġin 0.37966266
Ġour 0.46075845
Ġlong 2.2318554
- 0.013901056
term 0.024453795
Ġoutlook 2.4027283
, 1.4941915
bytes:\xe2\x80 1.8579247
bytes:\x9d 0.006605443
Ġsaid 0.9823829
ĠChief 1.8446177
ĠExecutive 0.57567215
ĠDavid 2.041991
ĠR 0.078182384
icks 0.0022936692
Ġin 1.2273202
ĠLilly 5.3460135
bytes:\xe2\x80 0.59278727
bytes:\x99 0.00037457785
s 0.00024906988
Ġsecond 1.7502818
- 0.05218519
quarter 0.00088851544
Ġearnings 0.22413771
Ġcall 0.73566324
. 0.34696385
ĠHowever 4.223798
, 0.0026386194
Ġthe 2.3131554
Ġcost 6.9798503
Ġto 2.5352416
Ġdevelop 1.0841079
Ġnew 0.977395
Ġdrugs 0.5178572
Ġand 1.99268
Ġgain 5.2431917
Ġregulatory 0.59634537
Ġapproval 0.5354887
Ġremains 2.2046034
Ġextremely 4.4824724
Ġhigh 0.17442347
Ġand 1.8346692
Ġuncertain 4.4819245
. 0.47787172
ĠLilly 1.7706584
Ġfaces 3.788886
Ġnumerous 5.1792226
Ġnear 6.311269
- 0.020682344
term 0.035698127
Ġchallenges 0.8843603
, 1.1385536
Ġincluding 0.27377018
Ġpatent 3.3442173
Ġexp 0.32298023
ir 0.20599394
ations 8.471396e-05
, 2.6030574
Ġpricing 3.026385
Ġpressures 0.70700675
Ġin 3.3529928
Ġthe 0.82252216
ĠU 0.5171656
. 7.4460135e-05
S 0.0053299405
. 0.28241625
Ġmarket 1.6143514
, 0.67274463
Ġand 0.5695594
Ġcompetitive 5.278511
Ġthreats 0.58463234
Ġfrom 0.48259345
Ġrival 4.5032215
Ġdrug 1.0411756
makers 0.4190171
. 0.40311182
ĠWhile 4.40683
ĠLilly 1.557356
bytes:\xe2\x80 1.1785922
bytes:\x99 0.00037994413
s 0.00021431445
Ġinnovation 6.340332
- 4.7105503
driven 0.8383035
Ġgrowth 1.4506243
Ġstrategy 0.39602482
Ġhas 1.2272271
Ġstarted 5.9880404
Ġto 0.20453916
Ġpay 0.64152503
Ġoff 0.047977526
, 0.48041815
Ġinvestors 1.9629734
Ġwill 0.65492743
Ġbe 0.8290225
Ġclosely 1.0110291
Ġmonitoring 1.5698477
Ġthe 0.74647814
Ġcompany 0.24892077
bytes:\xe2\x80 0.16002813
bytes:\x99 0.00021908467
s 0.00013407106
Ġmargins 3.1505485
Ġand 1.4912747
Ġpipeline 4.519969
Ġprogress 1.8367946
Ġto 1.8382492
Ġensure 2.9213054
Ġsustainable 2.3146257
Ġmomentum 6.657272
Ġin 1.9460001
Ġthe 0.23151258
Ġcoming 2.3548248
Ġquarters 0.3104066
. 0.12955375
